Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:m.limatoxi.com >> EN >> Pharmaceutical News
Changsheng finished the project of enzymatic method Amoxicillin2014-04-17
MZ-BIO-Chem to build Erythromycin oxime project2014-04-16
Jiangxi Tianxin is building R&D center in Shanghai2014-04-16
Zhejiang Tianxin stopped Vitamin B1 quoted prices2014-04-15
Zhejiang NHU increased Vitamin A and Vitamin E prices2014-04-15
Bal Pharma submitted anti-dumping investigation for China's Gliclazide2014-04-14
Huarong got CEP certificate for Vitamin B122014-04-11
DSM in exclusive discussions to acquire Aland2014-04-10
Shengda's Biotin and Folic Acid premixs passed completion monitoring2014-04-10
Porton's Nicotine got CEP certificate2014-04-04
Xinhua's sales value of chemical APIs increased in 20132014-04-03
Bayer to expand production capacity in China2014-04-02
HuaHai's operating income reach 2.29 bln Yuan in 20132014-04-02
CSPC's annual revenue in 20132014-04-01
United Laboratories's turnover increased in 20132014-04-01
Zhejiang Medicine's sales revenue down in 20132014-03-31
Changhai started normal production of high content vitamin E2014-03-28
Qifu to build Rifampicin APIs project2014-03-28
FarmaSino to build cephalosporin projects2014-03-27
Jiaozuo Joincare's sales revenue reached 689 mln Yuan in 20132014-03-26
China's bio-pharmaceutical output exceeds 2t yuan in 20132014-03-25
Hegno's sales revenue reached 415 mln in 20132014-03-25
China made significant achievements in controlling tuberculosis2014-03-24
Shixing is buidling APIs projects2014-03-21
BASF declares Force Majeure for citral and derivatives2014-03-20
Rongxin to build the projects of Rosuvastatin and Ezetimibe2014-03-20
Fangzheng to build Azithromycin and Simvastatin projects2014-03-19
China urges investigation into gelatin products2014-03-19
CFDA takes closer look at medical devices2014-03-18
China tightens checks on cod-liver oil products2014-03-18
Tianxin increased feed grade vitamin B6 price2014-03-18
Zhejiang NHU increased Vitamin E price2014-03-17
共4532个 页次:70/142页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
Baidu
map